Welcome to the e-CCO Library!

P744: Therapeutic gain of continued, long-term infliximab therapy in Crohn’s disease patients with response but non-remission after one year of infliximab therapy
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Buhl*, M.K. Borghede, J. Brynskov, C. Steenholdt, M. Rasmussen, M.A. Ainsworth

Created: Thursday, 21 February 2019, 9:14 AM
P745 Perianal disease in Crohn’s disease is associated with higher rate of hospitalisation and mortality despite a higher utilisation of biologics: Report from the epiIIRN cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O. ATIA1, N. Asayag1, G. Focht1, A. Cahan2, I. Dotan3, R. Balicer4, M. Gavish5, B. Feldman4, I. Brufman4, Z. Haklai6, D. Turner1, Israeli IBD Research Nucleus (IIRN)

Created: Thursday, 30 January 2020, 10:12 AM
P745: Impact of migration on IBD incidence in 8 European populations: results from Epicom 2010 inception cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Misra R.*1, Burisch J.2, Shaji S.3, Salupere R.4, Ellul P.5, Ramirez V.6, D'Incà R.7, Munkholm P.2, Arebi N.8

Created: Wednesday, 20 February 2019, 10:36 AM
P745: Incidence of indeterminate colitis in the EPIMAD registry decreases over the period 1988–2014
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Mayer*1, H. Sarter2,3, M. Fumery2,4, G. Savoye5, A. Leroyer3, L. Dauchet3, C. Gower-Rousseau2,3, B. Pariente1

Created: Friday, 22 February 2019, 9:41 AM
P745: Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gros, B.(1,2)*;Plevris, N.(1);Constantine-Cooke, N.(3,4);Lyons, M.(1);O'Hare, C.(1,5);Noble, C.(1);Arnott, I.D.(1);Jones, G.R.(1,6);Lees, C.W.(1,4);Derikx, L.A.A.P.(1,7,8);
Created: Friday, 14 July 2023, 11:12 AM
P745: Switching between anti-TNF originator and biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review
Year: 2018
Source: ECCO '18 Vienna
Authors:

J.P. Gisbert1,2,3,4*, M. Chaparro1,2,3,4

Created: Thursday, 21 February 2019, 9:14 AM
P746 Prevalence, features and outcomes of splachnic vein thrombosis in inflammatory bowel disease. A nationwide, retrospective study from the ENEIDA registry
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H. Masnou1, M. Mañosa2, L. Menchén3, F. Mesonero4, L. Bujanda5, J. Castro6, I. Gonzalez-Partida7, R. De Francisco8, F.J. García-Alonso9, M.J. García10, C. González-Muñoza11, J.M. Huguet12, M. Iborra13, N. Cano-Sanz14, E. Domènech Moral2, Eneida-GETECCU Registry

Created: Thursday, 30 January 2020, 10:12 AM
P746: Anthropometric measures in adolescents with inflammatory bowel disease: A population-based study
Year: 2018
Source: ECCO '18 Vienna
Authors:

I. Ghersin1*, L.H. Katz2, S. Daher3, R. Shamir4, A. Assa4

Created: Thursday, 21 February 2019, 9:14 AM
P746: Clinical characteristic of Crohn's disease patients in Polish population
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lodyga M.*1, Eder P.2, Gawron-Kiszka M.3, Hartleb M.3, Kierkus J.4, Klopocka M.5, Kukulska M.6, Linke K.7, Malecka-Panas E.8, Poniewierka E.6, Smola I.6, Rawa T.9, Regula J.9, Rydzewska G.1,10

Created: Wednesday, 20 February 2019, 10:36 AM
P746: Identification of Altered Microbial Genera at Baseline in Adalimumab Clinical Remitters and an Absence of Change in Total Microbial Composition Post Induction Treatment in the SERENE UC Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Morsy, Y.(1);Pivorunas, V.(2);Leitner, C.(3);Birchler, T.(4);Guay, H.(2);Scharl, M.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P746: Living with ulcerative colitis in Germany: quantifying the socioeconomic impact of moderate to severe ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Dignass*1, J. Waller2, J. C. Cappelleri3, L. Salese4, A. Kisser5, L. Dietz5, M. DiBonaventura6, R. Wood2, D. Bargo6

Created: Friday, 22 February 2019, 9:41 AM
P747 Adherence to ECCO guidelines for cancer surveillance is associated to the detection of early cancer: A retrospective, single-centre, cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T.L. PARIGI, G. Roda PhD, M. Allocca, F. Furfaro, L. Loy, A. Zilli, S. Bonovas, S. Danese, G. Fiorino

Created: Thursday, 30 January 2020, 10:12 AM
P747: A sharp increase of using biologics for IBD in Israel: a population- based report from the epiIIRN database
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

Y. Chowers1, N. Asayag*2, N. Dan3, G. Focht3, R. Balicer4, E. Zittan4, E. Matz5, I. Brufman4, B. Feldman4, A. Cahan6, N. Lederman7, I. Dotan4, E. Israeli8, D. Turner3

Created: Friday, 22 February 2019, 9:41 AM
P747: Extracolonic and colonic cancer risk in patients with ulcerative colitis and primary sclerosing cholangitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Jelaković M.*1, Brinar M.1,2, Turk N.1, Prijić R.1, Krznarić Z.1,2, Rustemović N.1,2, Cukovic-Cavka S.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P747: Predictors of thiopurine treatment failure in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S.H. Hwang1*, J.S. Koo1, K.H. Kang1, D.-w. Lee1, B.J. Lee2, Y.T. Jeen3

Created: Thursday, 21 February 2019, 9:14 AM
P747: The impact of COVID-19 on patients with Inflammatory Bowel Disease: A population-based study using artificial intelligence.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Moralejo Lozano, Ó.(1)*;Beneyto Martín, P.(2);Abanades Tercero, M.(1);Muñoz Rosas, C.(1);Ruano Díaz, L.(1);Salmoral Luque, R.(1);Gómez Rodríguez, R.(1);
Created: Friday, 14 July 2023, 11:12 AM
P748 Characteristics of inflammatory bowel diseases in different stage of adolescence
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K.J. Szántó1, A. Bálint1, R. Bor1, A. Fábián1, Á. Milassin1, M. Rutka1, Z. Szepes1, N. Vass2, T. Molnár1, K. Farkas1

Created: Thursday, 30 January 2020, 10:12 AM
P748: Clinical outcomes and prognostic factors of methotrexate therapy in combination with anti-TNF agents in inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Park1,2*, J.H. Cheon1,2, J.J. Park3, Y. Park1,2, S.J. Park1,2, T.I. Kim1,2, W.H. Kim1,2

Created: Thursday, 21 February 2019, 9:14 AM
P748: High stress and significant decrease in productivity in caregivers of IBD patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zand A., Kim B.D., Dvorsky M., Hommes D.W.

Created: Wednesday, 20 February 2019, 10:36 AM
P748: Pharmacokinetics, relative bioavailability, and dose proportionality of a tablet formulation of the sphingosine 1-phosphate-1 receptor modulator VTX002 (formerly OPL-002)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gregg, R.(1);Yun, C.(1)*;Naik, S.(1);Huyghe, M.(2);Harris, J.(2);Mohan, R.(1);Nuss, J.(1);Sandborn, W.J.(1);
Created: Friday, 14 July 2023, 11:12 AM